語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Introduction to biologic and biosimi...
~
SpringerLink (Online service)
Introduction to biologic and biosimilar product development and analysis
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Introduction to biologic and biosimilar product development and analysis/ by Karen M. Nagel.
作者:
Nagel, Karen M.
出版者:
Cham :Springer International Publishing : : 2018.,
面頁冊數:
xi, 109 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
標題:
Drug development. -
電子資源:
https://doi.org/10.1007/978-3-319-98428-5
ISBN:
9783319984285
Introduction to biologic and biosimilar product development and analysis
Nagel, Karen M.
Introduction to biologic and biosimilar product development and analysis
[electronic resource] /by Karen M. Nagel. - Cham :Springer International Publishing :2018. - xi, 109 p. :ill., digital ;24 cm. - AAPS introductions in the pharmaceutical sciences,2522-834X. - AAPS introductions in the pharmaceutical sciences..
Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars.
The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
ISBN: 9783319984285
Standard No.: 10.1007/978-3-319-98428-5doiSubjects--Topical Terms:
581824
Drug development.
LC Class. No.: RM301.25 / .N344 2018
Dewey Class. No.: 615.19
Introduction to biologic and biosimilar product development and analysis
LDR
:01638nam a2200337 a 4500
001
928867
003
DE-He213
005
20190307165500.0
006
m d
007
cr nn 008maaau
008
190626s2018 gw s 0 eng d
020
$a
9783319984285
$q
(electronic bk.)
020
$a
9783319984278
$q
(paper)
024
7
$a
10.1007/978-3-319-98428-5
$2
doi
035
$a
978-3-319-98428-5
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RM301.25
$b
.N344 2018
072
7
$a
TDCW
$2
bicssc
072
7
$a
MED072000
$2
bisacsh
072
7
$a
TDC
$2
thema
082
0 4
$a
615.19
$2
23
090
$a
RM301.25
$b
.N147 2018
100
1
$a
Nagel, Karen M.
$3
1209090
245
1 0
$a
Introduction to biologic and biosimilar product development and analysis
$h
[electronic resource] /
$c
by Karen M. Nagel.
260
$a
Cham :
$c
2018.
$b
Springer International Publishing :
$b
Imprint: Springer,
300
$a
xi, 109 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
AAPS introductions in the pharmaceutical sciences,
$x
2522-834X
505
0
$a
Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars.
520
$a
The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
650
0
$a
Drug development.
$3
581824
650
0
$a
Biologicals.
$3
1023555
650
1 4
$a
Pharmaceutical Sciences/Technology.
$3
768561
650
2 4
$a
Pharmacy.
$3
582411
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
830
0
$a
AAPS introductions in the pharmaceutical sciences.
$3
1208085
856
4 0
$u
https://doi.org/10.1007/978-3-319-98428-5
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入